Skip to content

Drug interactions

Buprenorphine + Pazopanib

Severity: Major

Buprenorphine and Pazopanib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pazopanib is labeled with a warning for QT prolongation and torsades de pointes, and buprenorphine may add to this risk. Pazopanib may also inhibit CYP3A4 weakly.

What this interaction means in plain words

Buprenorphine and Pazopanib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Buprenorphine belongs to Musculoskeletal; Pazopanib belongs to Oncology.

Evidence level: Low

Why it happens

Additive QT prolongation, with possible minor CYP3A4 inhibition.

What to do

Check baseline and periodic ECGs and electrolytes, and avoid other QT-prolonging drugs. Consider an alternative analgesic if the QTc rises significantly.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Buprenorphine and Pazopanib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Buprenorphine with Pazopanib?

MediHelp rates the interaction as major. Buprenorphine and Pazopanib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Pazopanib is labeled with a warning for QT prolongation and torsades de pointes, and buprenorphine may add to this risk. Pazopanib may also inhibit CYP3A4 weakly.

How serious is the interaction between Buprenorphine and Pazopanib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Check baseline and periodic ECGs and electrolytes, and avoid other QT-prolonging drugs. Consider an alternative analgesic if the QTc rises significantly.

What other medicines interact with Buprenorphine?

MediHelp also lists interactions of Buprenorphine with, for example, Alvimopan, Calcium / magnesium / potassium / sodium oxybates, Olanzapine / samidorphan. The full list is on the Buprenorphine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in